Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
LEO Pharma
With
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed written informed consent
Diagnosis of papulopustular rosacea (IGA score of moderate or severe) with a minimum of 12 and maximum of 50 inflammatory lesions (papules and/or pustules) and persistent erythema with or without telangiectasia
Free of any clinically significant disease which could interfere with the study
Willingness to follow all study procedures
Male or female patient at least 18 years of age
You may not be if
Subjects known to be non-responders to azelaic acid
Presence of dermatoses that might interfere with the rosacea diagnosis or the evaluation of treatment results
Ocular rosacea, phymatous rosacea
Any condition or therapy that in the opinion of the investigator may pose a risk to the patient of interfere with any evaluation in the study
Facial laser surgery in the 6 weeks prior to the study
Topical or systemic use of prescription or non-prescription medications to treat rosacea
Use of any agent other than the investigational drugs to treat rosacea during the study
Expected use or change in dose in the 90 days prior to the study of beta-blockers, vasodilators, NSAIDs, hormonal treatment or drugs causing acneiform eruptions
Known hypersensitivity to any ingredients of the investigational product formulation
Alcohol or drug abuse
Incapability of giving fully informed consent
Subject is dependent person, i.e., a relative/family member of the investigator and/or is a member of the investigator's staff
Participation in another clinical research study within the last 4 weeks before randomization in this study
